Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Full list of cell penetrating peptides | LifeTein Peptide Blog

Table 1 Selection of cell-penetrating peptides (Reference: https://doi.org/10.1007/978-981-13-8747-0, Ülo Langel, CPP, Cell-Penetrating Peptides, 2019) Name Sequence 2 DSLKSYWYLQKFSWR (Kondo et al. 2012) 18A DWLKAFYDKVAEKLKEAF (Datta et al. 2000) α1H KSKTEYYNA

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Table 1 Selection of cell-penetrating peptides

(Reference: https://doi.org/10.1007/978-981-13-8747-0, Ülo Langel, CPP, Cell-Penetrating Peptides, 2019)

Name

Sequence

2

DSLKSYWYLQKFSWR (Kondo et al. 2012)

18A

DWLKAFYDKVAEKLKEAF (Datta et al. 2000)

α1H

KSKTEYYNAWAVWERNAP (Gomarasca et al. 2017)

α2H

GNGEQREMAVSRLRDCLDRQA (Gomarasca et al. 2017)

A22p

HTPGNSNKWKHLQENKKGRPRR (Shin et al. 2014)

Ac-18A-NH2

DWLKAFYDKVAEKLKEAF) (Wimley and White 2000)

aCPP

Typical sequence R9GPLGLAGE8 (Li et al 2015)

AdVpVI(33-55)

Ac-GAFSWGSLWSGIKNFGSTVKNYG (Murayama et al. 2016)

AIP6

RLRWR (Wang et al. 2011)

all-d DsC18

Glrkrlrkfrnkikek (Bergmann et al. 2017)

αgliadin(31-43)

LGQQQPFPPQQPY (Paolella et al. 2018)

Alyteserin-2a

ILGKLLSTAAGLLSNL (Conlon et al. 2013)

ANG

TFFYGGSRGKRNNFKTEEY (Demeule et al. 2008)

ApoE(141–150)

Ac-LRKLRKRLLRX-Bpg-G (Shabanpoor et al. 2017)

ApoE-derived

Ac-LRKLRKRLLR (Tailhades et al. 2017)

Arf(1-22)

MVRRFLVTLRIRRACGPPRVRV (Johansson et al. 2008)

AT1002

FCIGRL (Gopalakrishnan et al. 2009)

AT1AR(304-318)

FLGKKFKKYFLQLLK (Östlund et al. 2005)

Bac7

RRIRPRPPRLPRPRPRPLPFPRPGPRPIPRPL (Sadler et al. 2002)

BGPC7-FHV

RRRRNRTRRNRRRVR-RRFYGPV (Wongso et al. 2017)

Bim

EIWIAQELRRIGDEFNAYYARLLC (Kim et al. 2017)

BP16

KKLFKKILKKL (Soler et al. 2014)

BP100

KKLFKKILKYL (Eggenberger et al. 2009)

BPP13a

GGWPRPGPEIPP (Sciani et al. 2017)

bPrPp(1-30)

MVKSKIGSWILVLFVAMWSDVGLCKKRPKP (Magzoub et al. 2006)

BR2

RAGLQFPVGRLLRRLLR (Lim et al. 2013)

Buforin II

TRSSRAGLQFPVGRVIIRLLRK (Park et al.1998)

Buforin IIb

RAGLQFPVG[RLLR]3 (Lee et al. 2008)

C6M1

RLWRLLWRLWRRLWRLLR (Jafari et al. 2014)

C105Y

CSIPPEVKFNKPFVYLI (Rhee and Davis 2006)

CADY

GLWRALWRLLRSLWRLLWRA cycteamide (Crombez et al. 2009a)

CAR

CARSKNKDC (Toba et al. 2014)

CA-Tat

KWKLFKKYGRKKRRQRRR (Lv et al. 2017)

CB5005 M

KLKLALALALA (Zhang et al. 2016)

CDB3

REDEDEIEW (Issaeva et al. 2003)

CendR

RPARPAR (Hu et al. 2014)

cF<tR4

cyclic F<tRRRRQ (Qian et al. 2014)

CGKRK

CGKRK (Griffin et al. 2017)

CIGB-300

cyclic CWMSPRHLGTC-Tat (Perera et al. 2012)

CIGB-552

Ac-HARIKpTFRRlKWKYKGKFW (Fernandez Masso et al. 2013)

CLIP6

KVRVRVRVpPTRVRERVK (Soudah et al. 2017)

CooP

ACGLSGLGVA (Hyvonen et al. 2014)

CpMTP

ARLLWLLRGLTLGTAPRRA (Jain and Chugh 2016)

CPNT

STSGTGKMTRAQRRAAARRNRA (Qi et al. 2011)

CPP1

(KFF)3K (Patel et al. 2017)

CPP33

RLWMRWYSPRTRAYG (Lin et al. 2018)

CPP-C

PIEVCMYREP (Nakayama et al. 2011)

CPPecp

NYRWRCKNQN (Fu et al. 2017)

C-peptide

GPGLWERQAREHSERKKRRRESECKAA (Fan et al. 2016)

CRGDK

CRGDK (Zhao et al. 2018)

Crotamine

YKQCHKKGGHCFPKEKICLPPSSDFGKMDCRWRWKCCKKGSG (Rodrigues et al. 2012)

cSN50

AAVALLPAVLLALLAPVQRKRQKLMP (Torgerson et al. 1998)

65-2CTS

CPYVNQRPQKARYRNG (Percipalle et al. 2003)

CWR8K

CWR8K (Sasaki et al. 2008)

CyLoP-1

CRWRWKCCKK (Ponnappan et al. 2017)

Cyt c(77–101)

GTKMIFVGIKKKEERADLIKKA (Howl and Jones 2015)

DAG

cyclic CDAGRKQKC (Mann et al. 2017)

D-JNKI-1

RPKRPTTLNLFPQVPRSQDT (Bonny et al. 2001)

DK17

DRQIKIWFQNRRMKWKK (Bera et al. 2016)

DLP

ACKTGSHNQCG (Kumar et al. 2015)

DMBT1-derived

GRVEVLYRGSW and GRVRVLYRGSW (Tuttolomondo et al. 2017)

dNP2

KIKKVKKKGRK-KIKKVKKKGRK (Lim et al. 2015)

DPV3

RKKRRRESRKKRRRES (Tacken et al. 2008)

DPV1047

CVKRGLKLRHVRPRVTRMDV (De Coupade et al. 2005)

DRTTLTN

DRTTLTN (Gennari et al. 2016)

DS4.3

RIMRILRILKLAR (Jeong et al. 2014)

Dynorphin A

YGGFLRRIRPKLKWDNQ (Marinova et al. 2005)

EA

GLKKLAELAHKLLKLGC (Yang et al. 2014)

EB1

LIRLWSHLIHIWFQNRRLKWKKK (Lundberg et al. 2007)

EF

GLKKLAELFHKLLKLGC (Yang et al. 2014)

EHB

RCSHYTGIRCSHMAATTAGIYTGIRCQHVVL-C6H (Cao et al. 2018)

EPRNEEK

EPRNEEK (Orihuela et al. 2009)

F3**

diphosphorylated dipeptide (Miao et al. 2016)

G4R9L4

G4R9L4 (Ramakrishna et al. 2014)

GALA

WEAALAEALAEALAEHLAEALAEALEALAA (Li et al. 2004)

GeT

KIAKLKAKIQKLKQKIAKLK (Rakowska et al. 2014)

gH625

HGLASTLTRWAHYNALIRAF (Galdiero et al. 2015)

Gi3α(346-355)

KNNLKECGLY (Jones et al. 2005)

Glu-Lys

EEEAAKKK (Lewis et al. 2010)

GV1001

EARPALLTSRLRFIPK (Kim et al. 2016a)

GWH1

GYNYAKKLANLAKKFANALW (Serna et al. 2017)

H2A derived

SGRGKQGGKARAKAKTRSSRAGLQFPVGRVHRLLRKG (Rosenbluh et al. 2004)

H6R6

H6R6 (Sun et al. 2017)

H16

H16 (Iwasaki et al. 2015)

HA2(1-23)

GLFGAIAGFIENGWEGMIDGWYG (Esbjörner et al. 2007)

HAIYPRH

HAIYPRH (Shteinfer-Kuzmine et al. 2017)

hBD3-3

GKCSTRGRKCCRRKK (Lee et al. 2015b)

HBP

GKRKKKGKGLGKKRDPCLRKYK (Luo et al. 2016)

hLF

KCFQWQRNMRKVRGPPVSCIKR (Duchardt et al. 2009)

Hph-1

YARVRRRGPRR (Jung et al. 2011)

HR9

CH5-R9-H5C (Liu et al. 2013a)

Hst5

DSHAKRHHGYKRKFHEKHHSHRGY (Luque-Ortega et al. 2008)

I1WL5W

WKKIWSKIKKLLK (Bi et al. 2014)

I4WL5W

IKKWWSKIKKLLK (Bi et al. 2014)

ID No.2

MAAWMRSLFSPLKKLWIRMH (Eudes and Macmillan 2014)

IMT-P8

RRWRRWNRFNRRRCR (Gautam et al. 2016)

INF

GLFEAIEGFIENGWEGMIDGWYGC (Pichon et al. 1997)

iNGR

CRNGRGPDC (Alberici et al. 2013)

isl-1

RVIRVWFQNKRCKDKK (Kilk et al. 2001)

JB9

cskc (Basu and Wickstrom, 1997)

JB434

R9GGLAA-Aib-SGWKH6 (Sangtani et al. 2018)

KAFAK

KAFAKLAARLYRKALARQLGVAA (Bartlett et al. 2013)

KALA

WEAKLAKALAKALAKHLAKALAKALKACEA (Wyman et al. 1997)

Kalata B1

polycyclic CGETCVGGTCNTPGCTCSWPVCTRNGLPV (Daly et al. 1999)

(KFF)3K

(KFF)3K (Rownicki et al. 2017)

K-FGF

AAVLLPVLLAAP (Lin et al. 1995)

KH

(KH)9 (Chuah et al. 2016)

KLA

KLAKLAKKLAKLAK (Huang et al. 2017)

KLAK

KLALKLALKALKAALKLA (Oehlke et al. 1998)

KLA-R7

KLAKLAKKLAKLAKGGRRRRRRR (Lemeshko, 2013)

KP

MAPTKRKGSCPGAAPNKKP (Villa-Cedillo et al. 2017)

KST peptide

STGKANKITITNDKGRLSK (Adachi et al. 2017)

L1−6

PLILLRLLR (Schmidt et al. 2017)

L5a

RRWQW (Liu et al. 2016a)

L17E

IWLTALKFLGKHAAKHEAKQQLSKL (Akishiba et al. 2017)

lactoferrampin(265- 284)

DLIWKLLSKAQEKFGKNKSR (Reyes-Cortes et al. 2017)

lactoferricin(17-30)

FKCRRWQWRMKKLG (Reyes-Cortes et al. 2017)

lactoferrin(19-40)

KCFMWQEMLNKAGVPKLRCARK (Duchardt et al. 2009)

LAH1

KKLALALALALHALALALALKKA (Moulay et al. 2017)

LALF(31-52)

HYRIKPTFRRLKWKYKGKFW (Yanez et al. 2017)

LB

FKCRRWQWRMKKLGAPSITCVRRAF) (Liu et al. 2013b)

L-CPP

LAGRRRRRRRRRK (Liu et al. 2006)

LDP-NLS

KWRRKLKKLRPKKKRKV (Ponnappan and Chugh, 2017)

LE10

LELELELELELELELELELE (Antunes et al. 2013)

LF chimera

FKCRRWQWRMKKLG-K-RSKNKGFKEQAKSLLKWILD (Reyes-Cortes et al. 2017)

linTT1

AKRGARSTA (Hunt et al. 2017)

LK

LKKLLKLLKKLLKLAG (Kim et al. 2016b)

LL37

LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES (Kim et al. 2016b)

LLIIL

LLIIL (Alaybeyoglu et al. 2017)

LMWP

VSRRRRRRGGRRRR (Chen et al. 2017d)

LP-12

HIITDPNMAEYL (Kumar et al. 2015)

LPAs

RCnRCnK (Gupta et al. 2011)

LTV

LTVSPWY (Chopra 2012)

lycosin-I

RKGWFKAMKSIAKFIAKEKLKEHL (Tan et al. 2017)

Lyp1

CGNKRTRGC (Fogal et al. 2008)

M918

MVTVLFRRLRIRRACGPPRVRV (El-Andaloussi et al. 2007)

Maurocalcine

GDCLPHLKLCKENKGCCSKKCKRRGTNIEKRCR (Poillot et al. 2010)

MAP

MAP12

LKTLTETLKELTKTLTEL (Oehlke et al. 2002)

MCoTI-I

polycyclic SGSDGGVCPKILQRCRRDSDCPGACICRGNGYCG (Camarero, 2017)

MCoTI-II

polycyclic CPKILKKCRRDSDCPGACICRGNGYCGSGSDGGV (Huang et al. 2015)

MFK

MFKLRAKIKVRLRAKIKL (Samuels et al. 2017)

Mgpe9

CRRLRHLRHHYRRRWHRFRC (Vij et al. 2016a)

MitP

INLKKLAKL(Aib)KKIL (Howl et al. 2018)

m(KLA)-iRGD

klaklakklakla-K-GG-iRGD (Qifan et al. 2016)

MMGP1

MLWSASMRIFASAFSTRGLGTRMLMYCSLPSRCWRK (Pushpanathan et al. 2013)

MPER fragment

ELDKWASLWNWFDITNWLWYIK (Song et al. 2009)

MPG

GALFLGFLGAAGSTMGA cysteamide (Morris et al. 1997)

GALFLGFLGAAGSTMGASQPKKKRKV cycteamide (Deshayes et al. 2005)

MPG-8

AFLGWLGAWGTMGWSPKKKRK (Crombez et al. 2009b)

mRVG

YTIWMPENPRPGTPCDIFTKSRGKRASNGGGRRRRRRRRR (Villa-Cedillo et al. 2017)

MT23

LPKQKRRQRRRM (Zhou et al. 2017)

mtCPP1

r-Dmt-OF (Cerrato et al. 2015)

MTM

AAVALLPAVLLALLAP (Fletcher et al. 2010)

MTD84

AVALVAVVAVA (Lim et al. 2014)

MTP

MLSLRQSIRFFK (Chuah et al. 2015a, b)

MTS

KGEGAAVLLPVLLAAPG (Zhao et al. 2001)

MTS1

AAVLLPVLLAAP (Rojas et al. 1998)

Mut3DPT-C9h

VKKKKIKAEIKIYVETLDDIFEQWAHSEDL (de la Torre et al. 2017)

Myr-ApoE

Myr-LRKLRKRLLR (Tajik-Ahmadabad et al. 2017)

New modalities

Polycyclic, hairpin, stapled peptides for delivery (Valeur et al. 2017, Waldmann et al. 2017)

NF1

Stearyl-AGY(PO3)LLGKTNLKALAALAKKIL (Arukuusk et al. 2013)

NF51

δ-(Stearyl-AGYLLG)OINLKALAALAKKIL (Arukuusk et al. 2013)

NF55

δ-(Stearyl-AGYLLG)OINLKALAALAKAIL (Freimann et al. 2016)

NLS

PKKKRKV (Yoneda et al. 1992).

NLS-StAx-h

stapled RRWPRXILDXHVRRVWR (Dietrich et al. 2017)

NoLS

KKRTLRKNDRKKRC (Yao et al. 2015)

Novicidin

KNLRRIIRKGIHIIKKYF (Milosavljevic et al. 2016)

NPFSD

VLTNENPFSDP (Gong et al. 2016)

NYAD-1

stapled ITFEDLLDYYGP (Zhang et al. 2008)

Oct4-PTD

DVVRVWFCNRRQKGKR (Adachi et al. 2017)

P007

Ac-(RAhxR)4-Ahx-βAla (Greer et al. 2014)

P1

LRRWSLG (Peng et al. 2017b)

P2

WKRTLRRL (Peng et al. 2017b)

P3

YGRKKRRQR (Tan et al. 2006)

P7

RRMKWKK (Watson et al. 2017)

P11

YGRKKRRQRRR (Zhao et al. 2011)

HSDVHK (Bang et al. 2011)

P11LRR

P11LRR (Li et al. 2010)

P14LRR

(PLPRPR)4 (Brezden et al. 2016)

p18

LSTAADMQGVVTDGMASG (Taylor et al. 2009)

P21

KRKKKGKGLGKKRDPCLRKYK (Dixon et al. 2016)

P28

LSTAADMQGVVTDGMASGLDKDYLKPDD, Leu50-Asp77 of azurin (Yamada et al. 2016)

p28

FLHSGTAVTCTYPALTPQWEGSDCTHRL (Signorelli et al. 2017)

p53 peptide MO6

Stapled TSF*EYWYLL* (Chee et al. 2014)

PAF26

Ac-rkkwfw (Lopez-Garcia et al. 2002)

PAS

GKPILFF (Woldetsadik et al. 2017)

pCLIP6

KVRVRVRVpP(pT)RVRERVK (Chen et al. 2017b)

pD-SP5

riPRPSPKMGV(pS)VS (Chen et al. 2017b)

PenetraMax

KWFKIQMQIRRWKNKR, L- and D- (Khafagy el et al. 2015)

Penetratin

RQIKIWFQNRRMKWKK (Derossi et al. 1994)

Pep-1

KETWWETWWTEWSQPKKKRKV cysteamide (Morris et al. 1997)

pepM

KLFMALVAFLRFLTIPPTAGILKRWGTI (Freire et al. 2014)

pepR

LKRWGTIKKSKAINVLRGFRKEIGRMLNILNRRRR (Freire et al. 2014)

Pept1

PLILLRLLRGQF (Marks et al. 2011)

Peptide 599

GLFEAIEGFIENGWEGMIDGWYGGGGRRRRRRRRRK (Alexander-Bryant et al. 2015)

Pep42

Cyclic CTVALPGGYVRVC (Kim et al. 2006)

PepNeg

SGTQEEY (Neves-Coelho et al. 2017)

PepFect6

Stearyl-AGYLLGK(εTMQ)INLKALAALAKKIL, PF6 (El-Andaloussi et al. 2011)

PepFect14

Stearyl- AGYLLGKLLOOLAAAALOOLL (Ezzat et al. 2011)

PG1

RGGRLCYCRRRFCVCVGR (Liu et al. 2013b)

pHLIP

AEQNPIY-WARYADWLFTTPLLLLDLALLV-DADEGT (Andreev et al. 2010)

PHPs

H6-H10 peptides (Kimura et al. 2017)

PIP1

RXRRXRRXRIKILFQNRRMKWKK (Ivanova et al. 2008)

Pip5e

RXRRBRRXRILFQYRXRBRXRB (Betts et al. 2012)

Pip6a

Ac-RXRRBRRXRYQFLIRXRBRXRB (Lehto et al. 2014)

POD

CGGG(ARKKAAKA)4 (Dasari et al. 2017)

PR9

FFLIPKG-R9 (Liu et al. 2013a)

PTD

YARVRRRGPRRR (Dong et al. 2016)

PTD3

R9-ETWWETWWTEW (Kizaka-Kondoh et al. 2009)

PTD4

YARAAARQARA (McCusker et al. 2007)

Poly-Arg

Most popular R7 – R12 (Mitchell et al. 2000, Futaki, 2006)

pVEC

LLIILRRRIRKQAHAHSK (Elmquist et al. 2001)

Pyrrhocoricin

VDKGSYLPRPTPPRPIYNRN (Otvos et al. 2000)

R4K1

Stapled Ac-RRRRKS*LHRS*LQDS (Speltz et al. 2018)

R6dGR

R6dGR (Wang et al. 2017)

R8

R8 (Wender et al. 2001)

R8-dGR

R8dGR (Liu et al. 2016b)

R9-H4A2

Ac-YR9-HAHAHH (Okitsu et al. 2017)

R6W3

R6W3 (Bechara et al. 2013)

R10W6

R10W6 (Bechara et al. 2013)

RA9

RRAARRARR (Alhakamy et al. 2013)

RALA

WEARLARALARALARHLARALARALRACEA (McCarthy et al. 2014)

RDP

CKSVRTWNEI IPSKGCLRVG GRCHPHVNGG GRRRRRRRRC (Xiao et al. 2017)

REDV

REDV (Yang et al. 2016)

RF

GLKKLARLFHKLLKLGC (Yang et al. 2014)

cRGDfC

Cyclic RGDfC (Wada et al. 2017)

iRGD

Cyclic CRGDKGPDC (Peng and Kopecek, 2015)

RGE

RGERPPR (Yu et al. 2017)

RH9

RRHHRRHRR (Alhakamy et al. 2013)

RL9

RRLLRRLRR (Alhakamy et al. 2013)

RL16

RRLRRLLRRLLRRLRR (Joanne et al. 2009)

RT53

RQIKIWFQNRRMKWKKAKLNAEKLKDFKIRLQYFARGLQV YIRQLRLALQGKT (Jagot-Lacoussiere et al. 2016)

RTP004

RKKRRQRRRG-K15-GRKKRRQRRR) (Lee et al. 2015a)

RV24

RRRRRRRRRGPGVTWTPQAWFQWV (Lo and Wang, 2012)

RVG

YTIWMPENPRPGTPCDIFTNSRGKRASNG (Kumar et al. 2007)

RVG-9R

YTIWMPENPRPGTPCDIFTNSRGKRASNGGGGRRRRRRRRR (Rassu et al. 2017)

RVG29

YTIWMPENPRPGTPCDIFTNSRGKRASNGGGGRRRRRRRRR (Villa-Cedillo et al. 2017)

RW9

RRWWRRWRR (Alhakamy et al. 2013)

RW16

RRWRRWWRRWWRRWRR (Jobin et al. 2013)

(RXR)4

(R-Ahx-R)4 (Saleh et al. 2010)

(rXr)4

(r-Ahx-r)4 (Vij et al. 2016b)

S155

VKKKKIKREI-KIAAQRYGRELRRMADEFHV (Haidar et al. 2017)

S4(13)-PV

ALWKTLLKKVLKAPKKKRKV (Mano et al. 2007)

SAP

VRLPPPVRLPPPVRLPPP (Pujals et al. 2006)

SAP(E)

VELPPPVELPPPVELPPP (Martin et al. 2011)

all-D-SAP

(vrlppp)3 (Pujals et al. 2007)

SAPSp-lipo

stearyl-GGGGHGAHEHAGHEHAAGEHHAHE (Suzuki et al. 2017)

SAR6EW

SAR6EW (Im et al. 2017)

sC18

GLRKRLRKFRNKIKEK (Oren et al. 1999)

(sC18)2

(GLRKRLRKFRNKIKEK)2 (Gronewold et al. 2017)

SMTP motif,

LRLLR (Fuselier and Wimley, 2017)

SPACE

Cyclic ACTGSTQHQCG (Hsu and Mitragotri, 2011)

SRCRP2-11

GRVEVLYRGSW (Tuttolomondo et al. 2017)

STR-KV

H3K3V6 (Pan et al. 2016)

SS-02

Dmt-r-FK (Alta et al. 2017)

SS-20

F-r-FK (Alta et al. 2017)

SS-31

r-Dmt-KF (Zhao et al. 2005)

SynB1

RGGRLSYSRRRFSTSTGR (Rousselle et al. 2000)

T2

LVGVFH (Kumar et al. 2012)

Tat(49-57)

RKKRRQRRR (Vives et al. 1997a)

Tat(48-60)

GRKKRRQRRRPPQ (Vives et al. 1997b)

Tat(44-57)

CGISYGRKKRRQRRR (Niesner et al. 2002)

Tat(37-72)

CFITKALGISYGRKKRRQRRRPPQGSQT-HQVSLSKQ (Fawell et al. 1994)

Tat analog

GRKKRRQR (Nguyen et al. 2008)

Tat-LK15

Tat-KLLKLLLKLLLKLLK (Peng et al. 2017a)

TCTP

MIIFRALISHKK (Bae et al. 2016)

TD-1

ACSSSPSKHCG (Chen et al. 2006)

TD2.2

SYWYRIVLSRTGRNGRLRVGRERPVLGESP (Heffernan et al. 2012)

TH peptide

GYLLGHINLHHLAHL-Aib-HHIL (Chen et al. 2017a)

TM2

PKKGSKKAVTKAQKKDGA (Kochurani et al. 2015)

Transportan

GWTLNSAGYLLGKINLKALAALAKKIL, TP (Pooga et al. 1998)

TP10

AGYLLGKINLKALAALAKKIL (Soomets et al. 2000)

TPk

VRRFkWWWkFLRR (Bahnsen et al. 2015)

Tpl

KWCFRVCYRGICYRRCRGK (Jain et al. 2015)

TPP

TKDNNLLGRFELSG (Gehrmann et al. 2014)

TT1

CKRGARSTA (Paasonen et al. 2016)

vAMP 059

INWKKWWQVFYTVV (Dias et al. 2017)

vCPP 0769

RRLTLRQLLGLGSRRRRRSR (Dias et al. 2017)

vCPP 2319

WRRRYRRWRRRRRWRRRPRR (Dias et al. 2017)

VDAC(1-26)

MAVPPTYADLGKSARDVFTKGYGFGL (Smilansky et al. 2015)

VP22

NAATATRGRSAASRPTQRPRAPARSASRPRRPVQ (Elliott and O’Hare, 1997)

V peptide

TVDNPASTTNKDKLFAVRK (Manosroi et al. 2014)

VT5

DPKGDPKGVTVTVTVTVTGKGDPKPD (Oehlke et al. 1997)

W(RW)4

W(RW)4 (Nasrolahi Shirazi et al. 2013)

Xentry

LCLR (Montrose et al. 2014)

X-pep

MAARLC (Adachi et al. 2017)

YKA

YKALRISRKLAK (Desai et al. 2014)

YTA2

YTAIAWVKAFIRKLRK (Lindgren et al. 2006)

YTA4

IAWVKAFIRKLRKGPLG (Lindgren et al. 2006)

Z2

FWIGGFIKKLKRSKLA (Chen et al. 2017c)

Z3

FKIKKFIGGLWRSKLA (Chen et al. 2017c)

Z12

KRYKNRVASRKCRAKFKQLLQHYREVAAAKSSENDRLRLLLK (Derouazi et al. 2015)

ZXR-1

FKIGGFIKKLWRSKLA (Chen et al. 2017c)

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Enhancing Intracellular Delivery for Research and Therapeutic Applications

Catalog Products » Catalog Peptide » Cell Penetrating Peptides-GenScript

Source: genscript.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →